 SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 PRNewswire -- VistaGen Therapeutics NASDAQ: VTGN, a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system CNS disorders, today reported its financial results for the fiscal... 